(Q34644769)
Statements
Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors (English)
Nicolas Isambert
Pierre Fumoleau
Christophe Ferrand
Sylvie Zanetta
Jacques Bauer
Kevin Ragot
Gérard Lizard
Jean-François Jeannin
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference